Propofol versus midazolam for sedation during radiofrequency ablation in patients with hepatocellular carcinoma

BACKGROUND AND AIM: Standardization of the sedation protocol during radiofrequency ablation (RFA) in patients with hepatocellular carcinoma (HCC) is needed. This randomized, single‐blind, investigator‐initiated trial compared clinical outcomes during and after RFA using propofol and midazolam, respe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanogawa, Naoya, Ogasawara, Sadahisa, Ooka, Yoshihiko, Inoue, Masanori, Wakamatsu, Toru, Yokoyama, Masayuki, Maruta, Susumu, Unozawa, Hidemi, Iwanaga, Terunao, Sakuma, Takafumi, Fujita, Naoto, Koroki, Keisuke, Kanzaki, Hiroaki, Maeda, Takahiro, Kobayashi, Kazufumi, Kiyono, Soichiro, Nakamura, Masato, Kondo, Takayuki, Saito, Tomoko, Motoyama, Tenyu, Suzuki, Eiichiro, Nakamoto, Shingo, Tawada, Akinobu, Chiba, Tetsuhiro, Arai, Makoto, Kanda, Tatsuo, Maruyama, Hitoshi, Kato, Jun, Takemura, Ryo, Nozaki‐Taguchi, Natsuko, Shiroh, Isono, Yokosuka, Osamu, Kato, Naoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857294/
https://www.ncbi.nlm.nih.gov/pubmed/33553667
http://dx.doi.org/10.1002/jgh3.12483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857294/
https://www.ncbi.nlm.nih.gov/pubmed/33553667
http://dx.doi.org/10.1002/jgh3.12483

Ejemplares similares